Inventor
LUCAS MATTHEW
US20 patents
⚠️ This page may combine multiple inventors who share the name “LUCAS MATTHEW”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN PHARMACEUTICA NV
7 patentsUS11970486B2Apr 30, 2024
Compounds and uses thereof
JANSSEN PHARMACEUTICA NV3 citations72
US12275723B2Apr 15, 2025
Compounds and uses thereof
JANSSEN PHARMACEUTICA NV1 citations61
US12180221B2Dec 31, 2024
Compounds and uses thereof
JANSSEN PHARMACEUTICA NV1 citations60
US12098146B2Sep 24, 2024
Compounds and uses thereof
JANSSEN PHARMACEUTICA NV0 citations60
US11873298B2Jan 16, 2024
Compounds and uses thereof
JANSSEN PHARMACEUTICA NV1 citations59
US12433880B2Oct 7, 2025
Methods for the treatment of neurological disorders
JANSSEN PHARMACEUTICA NV1 citations56
US12268687B2Apr 8, 2025
Compounds and uses thereof
JANSSEN PHARMACEUTICA NV0 citations50
CASTANEDO GEORGETTE
3 patentsUS8394796B2Mar 12, 2013
Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
CASTANEDO GEORGETTE8 citations82
US8173650B2May 8, 2012
Bicyclic pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
CASTANEDO GEORGETTE7 citations82
US8158625B2Apr 17, 2012
Bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
CASTANEDO GEORGETTE6 citations71
YUMANITY THERAPEUTICS INC
3 patentsUS10973810B2Apr 13, 2021
Methods for the treatment of neurological disorders
YUMANITY THERAPEUTICS INC7 citations79
US11241417B2Feb 8, 2022
Compositions and methods for the treatment and prevention of neurological disorders
YUMANITY THERAPEUTICS INC0 citations47
US10919885B2Feb 16, 2021
Compounds and uses thereof
YUMANITY THERAPEUTICS INC0 citations44